Longitudinal change in Paced Auditory Serial Addition Test (PASAT) performance following immunoablative therapy and haematopoietic stem cell transplant in multiple sclerosis

[1]  D. Arnold,et al.  Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis , 2017, Multiple sclerosis.

[2]  D. Arnold,et al.  Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial , 2016, The Lancet.

[3]  H. Atkins,et al.  Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study. , 2014, Multiple sclerosis and related disorders.

[4]  M. Freedman,et al.  Detecting cognitive fatigue in multiple sclerosis: Method matters , 2012, Journal of the Neurological Sciences.

[5]  D. Altmann,et al.  Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis , 2012, Journal of Neurology.

[6]  R. Whelan,et al.  Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients , 2011, Journal of the Neurological Sciences.

[7]  Stephen M. Smith,et al.  A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.

[8]  D. Arnold,et al.  Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  P. Parizel,et al.  Correlation of cognitive dysfunction and diffusion tensor MRI measures in patients with mild and moderate multiple sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.

[10]  R. Benedict,et al.  Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test , 2010, Multiple sclerosis.

[11]  G. Borm,et al.  Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a , 2010, Journal of Neurology.

[12]  L. Kappos,et al.  Hematopoietic stem cell transplantation in multiple sclerosis , 2009, Acta neurologica Scandinavica.

[13]  F. Paul,et al.  Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis , 2009, Neurology.

[14]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[15]  C. Bielajew,et al.  Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment , 2009, Psycho-oncology.

[16]  P. Brooks,et al.  Stem cell transplantation for autoimmune diseases , 2009, Springer Seminars in Immunopathology.

[17]  V. Dousset,et al.  Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study , 2008, Multiple sclerosis.

[18]  J. Ranjeva,et al.  Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study , 2008, Multiple sclerosis.

[19]  KS Cardinal,et al.  A longitudinal fMRI study of the paced auditory serial addition task , 2008, Multiple sclerosis.

[20]  M. Filippi,et al.  A Three-Year Study of Brain Atrophy after Autologous Hematopoietic Stem Cell Transplantation in Rapidly Evolving Secondary Progressive Multiple Sclerosis , 2007, American Journal of Neuroradiology.

[21]  M. Freedman.  Bone marrow transplantation: Does it stop MS progression? , 2007, Journal of the Neurological Sciences.

[22]  K. Koivisto,et al.  One-year follow-up study of relapsing-remitting MS patients' cognitive performances: Paced Auditory Serial Addition Test's susceptibility to change , 2007, Journal of the International Neuropsychological Society.

[23]  P. Morgan,et al.  Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[24]  D. Arnold,et al.  Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis , 2006, Neurology.

[25]  Dieter Vaitl,et al.  Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing–remitting MS , 2006, NeuroImage.

[26]  C. Bielajew,et al.  A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer , 2006, The Clinical neuropsychologist.

[27]  T. Tombaugh,et al.  A comprehensive review of the Paced Auditory Serial Addition Test (PASAT). , 2006, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[28]  D. Farge,et al.  Progress in hematopoietic stem cell transplantation for autoimmune diseases , 2005, Expert review of clinical immunology.

[29]  V. Shilling,et al.  The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. , 2005, Breast.

[30]  Bertrand Audoin,et al.  Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis , 2005, Human brain mapping.

[31]  Alessandra Solari,et al.  The multiple sclerosis functional composite: different practice effects in the three test components , 2005, Journal of the Neurological Sciences.

[32]  G. Comi,et al.  Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[34]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[35]  S. Rodenhuis,et al.  Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  A. Dale,et al.  Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain , 2002, Neuron.

[37]  C. Polman,et al.  A study validating changes in the multiple sclerosis functional composite. , 2002, Archives of neurology.